Login    Join free Add to favorites    中文
Home > Request Information
Title:
Vaximm AG Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
 refresh

SiteMap
Copyright(C) 2006-2026 Bio-Equip E-mail:web@bio-equip.cn Tel:+86-17717806891 (Wechat)